Healthcare Practice Valuation Multiples 2026: What Is Your Clinic Worth?
If you own a healthcare practice, whether it is a primary care clinic, dental practice, dermatology office, urgent care center, or specialty group, you are operating in one of the most actively acquired sectors in the lower middle market. Private equity firms, hospital systems, and management service organizations (MSOs) have been consolidating healthcare practices at an accelerating pace, and 2026 shows no signs of slowing down. Healthcare is one of the most recession-resistant sectors in the economy, people get sick regardless of market conditions, and an aging population is driving sustained demand growth across nearly every specialty.
2026 EBITDA Multiples by Healthcare Specialty
| Healthcare Specialty | Typical EBITDA Multiple |
|---|---|
| Primary Care / Family Medicine | 5x to 8x |
| Dental (General) | 5x to 7x |
| Dental (Specialty: Ortho, Perio, Oral Surgery) | 6x to 9x |
| Dermatology | 7x to 12x |
| Ophthalmology / Optometry | 6x to 10x |
| Urgent Care | 5x to 8x |
| Physical Therapy / Rehab | 5x to 8x |
| Behavioral Health / Mental Health | 6x to 10x |
| Medical Aesthetics / Med Spa | 5x to 9x |
| Veterinary | 6x to 10x |
The Valuation Drivers That Matter Most
Payor mix is one of the most important and most overlooked valuation drivers in healthcare. Buyers categorize your revenue by source. Commercial insurance including Blue Cross, Aetna, and United generates the highest reimbursement rates and is valued most highly. Medicare is stable and predictable but subject to legislative changes. Medicaid has low reimbursement rates and a high Medicaid percentage reduces your multiple. Self-pay and cash-pay can be positive for cosmetic and elective services with strong margins or negative for uncompensated care. A practice with 70% or more commercial insurance revenue will command a meaningfully higher multiple than one with 50% Medicaid. If you can improve your payor mix before going to market by adding commercial-heavy services, negotiating better contracts, or selectively growing in commercially insured demographics, it directly impacts your valuation.
If you are the sole provider generating all patient revenue, buyers see a significant risk regarding what happens to the practice when you leave. The best-positioned practices have multiple providers generating revenue including associates, PAs, and NPs, a clinical director or managing partner who can lead day-to-day operations, employment agreements with non-competes for associate providers, and low provider turnover over the past 3 to 5 years. Multi-location practices consistently command 1 to 2 additional multiple turns over single-site clinics because they demonstrate the model is replicable, the practice is not dependent on a single lease or geography, and there is an operational infrastructure supporting scale. Ancillary services including in-house lab and diagnostic imaging, physical therapy, pharmacy, aesthetic services, and nutritional counseling generate incremental revenue at high margins and buyers pay premiums for these established streams.
The MSO Model: How PE Structures Healthcare Deals
Most private equity acquisitions of healthcare practices use a Management Service Organization (MSO) structure. The MSO acquires the non-clinical business assets including billing, marketing, facilities, admin staff, and equipment. The clinical practice remains owned by a licensed physician due to corporate practice of medicine laws in most states. The MSO provides management services to the clinical practice under a long-term agreement. This structure allows PE firms to invest in healthcare while complying with regulations that prevent non-physicians from owning clinical practices. Healthcare practice deals often include 50 to 70% cash at close, 10 to 20% as a seller note, 10 to 20% as an earnout typically tied to provider retention or patient volume, and 5 to 20% as equity rollover in PE deals. The equity rollover component is increasingly significant. If the PE platform executes its roll-up strategy and sells to a larger firm in 3 to 5 years, the rollover equity can generate substantial additional returns sometimes rivaling the initial cash payment.
If you are exploring what your healthcare practice might be worth, Breakwater M&A offers confidential valuation consultations.
FAQs
What multiple should I expect for my healthcare practice?
Multiples vary by specialty, but most practices in the lower middle market trade between 5x and 10x EBITDA. Dermatology and behavioral health command the highest multiples, while general primary care and dental sit in the 5x to 8x range. Multi-location and multi-provider practices earn premiums.
How does payor mix affect my valuation?
Significantly. Practices with 70% or more commercial insurance revenue command higher multiples because commercial payors reimburse at higher rates. High Medicaid percentages reduce your multiple because margins are thinner and reimbursement is less reliable.
Should I sell to a hospital system or a PE-backed platform?
Both are viable paths with different trade-offs. Hospital systems may offer employment stability but typically pay lower multiples. PE-backed platforms often pay higher upfront multiples and offer equity rollover for potential future upside, but expect more aggressive growth targets.
How long is the typical transition period?
Most healthcare practice sales involve a 12 to 24 month transition period, often tied to an earnout. The founding physician typically continues to see patients during this period while management responsibilities transfer to the acquirer.
Recommended Reading
- Home Care Agency Valuation Multiples 2026: What is Your Business Worth? — Valuation benchmarks for the home health sector.
- Private Equity Rollovers: How to Sell Your Company Twice — Understanding the equity rollover opportunity in PE-backed healthcare deals.
- How to Sell Your Business to Private Equity — A step-by-step playbook for owners selling to financial buyers.
- EBITDA Multiples by Industry (2026) — Cross-industry valuation benchmarks for perspective.
- Exit Planning Guide (2026) — A step-by-step preparation checklist before going to market.
Key Takeaways
- Specialty matters. Dermatology, behavioral health, and ophthalmology command the highest multiples at 7x to 12x EBITDA, while general primary care and dental range from 5x to 8x.
- Payor mix is critical. Commercial insurance-heavy practices command meaningfully higher valuations than Medicaid-dependent ones.
- Multi-location practices command a 1 to 2 turn premium over single-site clinics consistently.
- Provider dependency discounts are real. Single-provider practices face lower multiples and longer earnouts. Build a team of associates before going to market.
- Ancillary revenue adds value. In-house lab, imaging, physical therapy, and aesthetic services generate high-margin revenue that buyers pay premiums for.
- Equity rollover opportunity in PE-backed deals can generate substantial additional returns if the platform executes well.